Ultrasound-guided costotransverse block with systemic adjuvants for complete opioid-free breast cancer surgery: A randomized controlled trial.
T M Banish, Priyanka Sethi, Rhythm Mathur, Deepanshu Dang, Manbir Kaur, Kamlesh Kumari, Nivedita Sharma, Pradeep Kumar Bhatia
J Anaesthesiol Clin Pharmacol 42(4) 557-564
摘要
摘要
BACKGROUND AND AIMS: Modified radical mastectomy (MRM) is associated with significant postoperative pain requiring opioid analgesia. Opioids carry undesirable effects including nausea, sedation, respiratory depression, opioid-induced hyperalgesia, and potential immune suppression that may impact oncological outcomes. This randomized controlled trial assessed the effectiveness of opioid-free anesthesia using ultrasound-guided costotransverse block (CTB) with multimodal systemic adjuvants on analgesic outcomes and recovery quality in breast cancer surgery. MATERIAL AND METHODS: This prospective, open-label, randomized controlled trial was conducted at tertiary care center with institutional ethics approval. Sixty-six female patients (American society of anesthesiologist physical staus grade(ASA) I-III) undergoing MRM were randomly allocated (1:1) to opioid-based anesthesia (Group A, n = 33) or opioid-free anesthesia with T4-level CTB using 0.5% ropivacaine (15 mL) plus dexmedetomidine (0.5 µg/kg/h), lidocaine (1.5 mg/kg bolus, 2 mg/kg/h infusion), and magnesium sulfate (30 mg/kg over 20 minutes) (Group B, n = 33). The primary outcome was 24-h fentanyl consumption. Secondary outcomes included intraoperative opioid requirements, time to first rescue analgesia, pain scores, quality of recovery-15 at 48 h, and complications. RESULTS: Complete elimination of perioperative opioid requirements was achieved in Group B. Intraoperative fentanyl consumption in Group B was 0 µg vs Group A 150 (132.5-150) µg (P < 0.001). Postoperative 24-h fentanyl consumption was Group B 0 µg vs Group A 60 (40-60) µg (P < 0.001). None of the Group B patients (0%) required rescue analgesia in comparison to Group A patients (100%), who required rescue analgesia at a median of 3 (3-4) h (P < 0.001). Pain scores were significantly lower in Group B at all time points during rest and movement (P < 0.001). Quality of recovery scores were superior in Group B: 128 (122-130) vs 88 (84-90) (P < 0.001). Postoperative nausea and vomiting incidence was reduced: 6% vs 24% (P = 0.086, not statistically significant). No block-related complications occurred. CONCLUSIONS: Ultrasound-guided CTB with multimodal systemic adjuvants provided complete elimination of perioperative opioid requirements while achieving superior pain control, enhanced recovery quality, and excellent safety in MRM. This opioid-free approach offers a clinically viable alternative to conventional opioid-based techniques. This approach can be a safe inclusion in enhanced recovery protocols for breast cancer surgery.
KM 提取结果
0 个 Figure · 0 个 KM 面板